{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:10:57Z","timestamp":1760004657472,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jpba.2023.115439","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T14:23:50Z","timestamp":1683123830000},"page":"115439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A feasible HPTLC method for concurrent quantitation of allopurinol-montelukast co-therapy in plasma and evaluation of their hepatic and renal effects in rats: Analytical, biochemical, and histopathological study"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-7702","authenticated-orcid":false,"given":"Noha M.","family":"Hosny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia M.","family":"Badary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Salem","family":"Hareedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2023.115439_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.jpba.2023.115439_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.semarthrit.2019.11.009","article-title":"Beyond urate lowering: analgesic and anti-inflammatory properties of allopurinol","volume":"50","author":"Schlesinger","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jpba.2023.115439_bib3","first-page":"1","article-title":"The prospective effect of allopurinol on the oxidative stress index and endothelial dysfunction in Covid-19","author":"Al-Kuraishy","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.jpba.2023.115439_bib4","doi-asserted-by":"crossref","unstructured":"M. Daniyali, L. Mahmoudieh, G. Afzal, F. Hematian, O. Moradi,. Eval. anti-Inflamm. Eff. allopurinol Diabet. Patients Chronic Kidney Dis. (dm-ckd): a Clin. Study 2021 doi:\u00a010.21203\/rs.3.rs-585871\/v1.","DOI":"10.21203\/rs.3.rs-585871\/v1"},{"issue":"8","key":"10.1016\/j.jpba.2023.115439_bib5","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/liv.14903","article-title":"Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles","volume":"41","author":"Fontana","year":"2021","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.jpba.2023.115439_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-019-2011-y","article-title":"Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study","volume":"21","author":"Rey","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.jpba.2023.115439_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02770903.2013.822081","article-title":"Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities","volume":"51","author":"Pacheco Yves","year":"2014","journal-title":"J. Asthma"},{"issue":"18","key":"10.1016\/j.jpba.2023.115439_bib8","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1039\/C8AN00772A","article-title":"Innovative HPTLC method with fluorescence detection for assessment of febuxostat\u2013montelukast combination and study of their protective effects against gouty arthritis","volume":"143","author":"Hosny","year":"2018","journal-title":"Analyst"},{"issue":"7","key":"10.1016\/j.jpba.2023.115439_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/ddr.21581","article-title":"Montelukast modifies simvastatin\u2010induced myopathy and hepatotoxicity","volume":"80","author":"Hareedy","year":"2019","journal-title":"Drug Dev. Res."},{"issue":"7","key":"10.1016\/j.jpba.2023.115439_bib10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00228-017-2242-2","article-title":"The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field","volume":"73","author":"Hoxha","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115439_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120707","article-title":"Ameliorative effect of montelukast against carbon tetrachloride-induced hepatotoxicity: Targeting NLRP3 inflammasome pathway","author":"El-Kashef","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.jpba.2023.115439_bib12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fphar.2019.01070","article-title":"Montelukast prevents mice against acetaminophen-induced liver injury","volume":"10","author":"Pu","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jpba.2023.115439_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jsps.2021.12.013","article-title":"Interference with megalin expression\/endocytic function by montelukast mitigates gentamicin nephrotoxicity: Downregulation of ClC-5 expression","volume":"30","author":"Azouz","year":"2022","journal-title":"Saudi Pharm. J."},{"issue":"2","key":"10.1016\/j.jpba.2023.115439_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08923973.2021.1878213","article-title":"Ameliorating effect of leukotriene receptor antagonist in multi-organ toxicity induced in rat offspring, a possible role for epidermal growth factor","volume":"43","author":"Abdelzaher","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.jpba.2023.115439_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5558651","article-title":"A Brief review of analytical methods for the estimation of allopurinol in pharmaceutical formulation and biological matrices","volume":"2021","author":"Sharma","year":"2021","journal-title":"Int. J. Anal. Chem."},{"issue":"9","key":"10.1016\/j.jpba.2023.115439_bib16","first-page":"2987","article-title":"Estimation of allopurinol \u2013 a review","volume":"10","author":"Ch Jaswanth Kumar","year":"2021","journal-title":"Int. J. Biol. Pharm. Allied Sci."},{"issue":"4","key":"10.1016\/j.jpba.2023.115439_bib17","first-page":"665","article-title":"A review on analytical method development for simultaneous estimation and validation of Montelukast Sodium and Bilastine","volume":"10","author":"Vairagi","year":"2021","journal-title":"World J. Pharm. Res."},{"issue":"3","key":"10.1016\/j.jpba.2023.115439_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/10408347.2019.1709410","article-title":"A Review of different analytical techniques for fexofenadine hydrochloride and montelukast sodium in different matrices","volume":"51","author":"Nalini","year":"2021","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115439_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpba.2017.11.077","article-title":"Improved bioautographic assay on TLC layers for qualitative and quantitative estimation of xanthine oxidase inhibitors and superoxide scavengers","volume":"150","author":"Kong","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115439_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jpba.2018.05.040","article-title":"Study of degradation behaviour of montelukast sodium and its marketed formulation in oxidative and accelerated test conditions and prediction of physicochemical and ADMET properties of its degradation products using ADMET Predictor\u2122","volume":"158","author":"Tiwari","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115439_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113657","article-title":"A simple and sensitive HPLC-MS\/MS assay for the quantitation of montelukast in cell-based systems in vitro pulmonary drug permeability study","volume":"192","author":"Wang","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115439_bib22","unstructured":"European Medicines Agency Guideline on Bioanalytical Method Validation (2011). London, United Kingdom, \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf\u3009 (accessed 18 June2022)."},{"key":"10.1016\/j.jpba.2023.115439_bib23","unstructured":"Shannon P. Williams, Division of pulmonary drug products review of pharmacology and toxicology data, (1998). \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/98\/020829s000_Singular_Pharma.pdf\u3009 (accessed 30 May 2022)."},{"issue":"9\u201310","key":"10.1016\/j.jpba.2023.115439_bib24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1159\/000516495","article-title":"Comparing the effects of febuxostat and allopurinol in an animal model of metabolic syndrome","volume":"106","author":"Nadwa","year":"2021","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.jpba.2023.115439_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1309\/42D6-W7PL-FX0A-LBXF","article-title":"Pathologic features of chronic hepatitis: a review and update","volume":"113","author":"Ishak","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.jpba.2023.115439_bib26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4314\/tjpr.v12i6.16","article-title":"Amelioration of cisplatin-induced nephrotoxicity in rats by curcumin and \u03b1-tocopherol","volume":"12","author":"Palipoch","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"issue":"7","key":"10.1016\/j.jpba.2023.115439_bib27","article-title":"Simultaneous estimation of lesinurad and allopurinol by using reverse phase high performance liquid chromatography in api and marketed formulation","volume":"3","author":"Dastiagiriamma","year":"2018","journal-title":"Innov. Int. J. Med. Pharm. Sci."},{"issue":"04","key":"10.1016\/j.jpba.2023.115439_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21477\/ijapsr.4.4.1","article-title":"Development and validation of reverse phase HPLC method for simultaneous estimation of allopurinol and lesinurad in its API and pharmaceutical dosage form","volume":"4","author":"Khader","year":"2019","journal-title":"Int. J. Appl. Pharm. Sci. Res."},{"issue":"4","key":"10.1016\/j.jpba.2023.115439_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/22297928.2018.1445556","article-title":"HPTLC-densitometric determination of allopurinol and its metabolite oxypurinol in human plasma and allopurinol in tablet dosage form","volume":"8","author":"Pandya","year":"2018","journal-title":"Anal. Chem. Lett."},{"issue":"4","key":"10.1016\/j.jpba.2023.115439_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/2229-4708.93390","article-title":"High performance liquid chromatographic method development for simultaneous analysis of doxofylline and montelukast sodium in a combined form","volume":"2","author":"Ethiraj","year":"2011","journal-title":"Pharm. Methods"},{"key":"10.1016\/j.jpba.2023.115439_bib31","article-title":"Method development and validation for the simultaneous determination of fexofenadine hydrochloride and montelukast sodium in drug formulation using normal phase high-performance thin-layer chromatography","author":"Tandulwadkar","year":"2012","journal-title":"Int. Sch. Res. Not."},{"issue":"2","key":"10.1016\/j.jpba.2023.115439_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264627","article-title":"Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression","volume":"17","author":"Park","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpba.2023.115439_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0021-5198(19)43420-3","article-title":"Possible mechanism responsible for allopurinol-nephrotoxicity: lipid peroxidation and systems of producing-and scavenging oxygen radicals","volume":"45","author":"Suzuki","year":"1987","journal-title":"Jpn. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.jpba.2023.115439_bib34","first-page":"723","article-title":"The possible effects of montelukast against doxorubicin-induced nephrotoxicity in rabbits","volume":"2","author":"Al-Saedi","year":"2014","journal-title":"Int. J. Adv. Res."},{"issue":"3","key":"10.1016\/j.jpba.2023.115439_bib35","first-page":"612","article-title":"Influence of montelukast on cisplatin-induced experimental acute renal failure","volume":"118","author":"Teslariu","year":"2014","journal-title":"Med. -Surg. J."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852300208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852300208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:28:59Z","timestamp":1760002139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852300208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":35,"alternative-id":["S073170852300208X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115439","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A feasible HPTLC method for concurrent quantitation of allopurinol-montelukast co-therapy in plasma and evaluation of their hepatic and renal effects in rats: Analytical, biochemical, and histopathological study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115439"}}